United States: Healthcare

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

AI In Health Care Is Scaling Quickly—As Regulation Lags, Internal Controls Need To Keep Pace

Recent developments suggest that major health care and life sciences organizations are expanding their use of AI beyond trial initiatives and targeted applications, while federal and state...

United States Healthcare

BS

Butler Snow LLP

Skin Substitutes: $3.2 Million ALJ Decision For Florida Wound Care Practice

Foley & Lardner LLP achieved a significant victory for a Florida wound care clinic, overturning over $3.2 million in Medicare overpayments that were improperly assessed based on the characterization of skin...

United States Healthcare

FL

Foley & Lardner

Warning Signs: Potential Congressional Investigations In Healthcare

For the remainder of the 119th Congress – and into the 120th Congress if Democrats gain control of one or both chambers – the healthcare industry should expect sustained congressional investigations across a broad...

United States Healthcare

HK

Holland & Knight

Innovative Insights: Legal Updates In The Life Sciences

This comprehensive legal update examines critical developments affecting the life sciences industry, including the surge in trade secret litigation, heightened scrutiny of employer health plan administration...

United States Healthcare

JD

Jones Day

DOJ’s Civil Fraud Section Announces “FOCUS” Initiative, Bolstering FCA Enforcement Capabilities

United States Government

DS

Dinsmore & Shohl

No AI Law, No Problem: Pennsylvania Applies Its Medical Practice Act To An AI Chatbot

United States Healthcare

DM

Duane Morris LLP

Trump Administration Updates For The Life Sciences Industry Q1 2026

United States Healthcare

JD

Jones Day

DOL’s Proposed PBM Fee Disclosure Rule: Key Themes From The Public Comments

United States Healthcare

M

Mintz

PepsiCo, ERISA Litigation, And Modification To Retiree Health Benefits Programs: What Employers Need To Know

United States Employment

HB

Hall Benefits Law

Tennessee’s FAIR Rx Act Marks A Major Escalation In State PBM Reform

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Decentralized Clinical Trials: Key Sponsor Considerations Under FDA And EMA Guidance

United States Healthcare

CM

Crowell & Moring LLP

Discounts? For Spring? Groundbreaking

United States Finance

SR

McDermott Will & Schulte

Podcast - The New Rules Of Healthcare Fraud Enforcement

United States Healthcare

HK

Holland & Knight

Critical Considerations For AI Model Licensing Agreements In Healthcare

United States Healthcare

FH

Foley Hoag LLP

Federal Circuit: Priority Document That 'Broadly Outlines' Possible Structures Fails To Provide Adequate Written Description Support For Subgenus Of Linkers In Antibody-Drug Conjugate

United States IP

AG

Akin Gump Strauss Hauer & Feld LLP

For Whom The Discovery Tolls: Your Privacy Notice May Help Time-Bar Website Wiretapping Claims

United States Privacy

FR

Fox Rothschild LLP

Congress Proposes Major Overhaul Of WARN: What Employers Need To Know About The Fair Warning Act

United States Employment

PR

Proskauer Rose LLP

The Empty Chair At Johannesburg: What It Says About US Power

United States International

SJ

Steptoe LLP

Hot Topics In International Trade BLG Newsletter Articles And Upcoming Events

United States International

BG

Braumiller Law Group, PLLC

The New York Appellate Division’s First PSQIA Decision Denies Privilege Protection

In Adams v. Bassett Healthcare Network, New York’s Appellate Division, Third Department directed disclosure of documents claimed to be privileged under the 2005 Patient Safety and Quality Improvement Act (PSQIA) in the state’s first appellate-level decision involving this federal protection from disclosure in litigation.

United States Litigation

WE

Wilson Elser Moskowitz Edelman & Dicker LLP

Virtual & Digital Health Digest

This digest covers key virtual and digital health regulatory and public policy developments during March and early April 2026 from the United States, United Kingdom, and European Union.

United States Healthcare

AP

Arnold & Porter

AbbVie Regulatory Submission And Deal News

AbbVie advances its SKYRIZI subcutaneous treatment for Crohn's disease with FDA submission, while investing $1.4 billion in a North Carolina manufacturing campus.

United States Healthcare

GP

Goodwin Procter LLP

FinCEN Raises Alarm On Healthcare Fraud

On March 30, 2026, the U.S. Department of the Treasury (the Treasury) Financial Crimes Enforcement Network (FinCEN) issued an Advisory urging financial institutions to step up their detection and reporting of suspicious transactions tied to Medicare, Medicaid, and other healthcare benefit program fraud schemes.

United States Healthcare

AP

Arnold & Porter

Benefits Counselor – April 2026

United States Employment

RB

Reinhart Boerner Van Deuren s.c.

Emerging Alternatives For GLP-1 Prescription Drug Coverage: What Plan Sponsors Need To Know

United States Employment

BB

Bass, Berry & Sims

Seventh Circuit Reins In BIPA Exposure

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

Relief, Finally? DEA Issues Order Expediting Cannabis Rescheduling To Schedule III

United States Cannabis

DM

Duane Morris LLP

DEA Application Portal For Expedited Registration Of Medical Marijuana Dispensaries Is Now Open

United States Cannabis

FH

Foley Hoag LLP

The Illusion Of PBM Transparency: What Plan Sponsors Must Learn From The OPM OIG Audit Of CVS Caremark

United States Finance

BI

Buchanan Ingersoll & Rooney PC

Introducing The Healthcare Class Action Review – 2026: A Deep Dive Into Healthcare Litigation Trends

United States Healthcare

DM

Duane Morris LLP

DOJ’s FOCUS On Data-Mining Whistleblowers

United States Criminal

WR

Wiley Rein

FDA Turns Up The Heat On GLP 1 Dupes Sold “For Research Use Only,” Finds Intended Use Suggests Otherwise (Podcast)

United States Healthcare

KD

Kelley Drye & Warren LLP

AI Regulation: The New Compliance Frontier

United States Healthcare

HK

Holland & Knight

AI Regulation: The New Compliance Frontier

As artificial intelligence rapidly transforms healthcare delivery and operations, a complex regulatory landscape is emerging across federal and state levels. With over 250 AI-related healthcare bills introduced in state legislatures in 2025 and the Trump Administration proposing a unified federal framework, stakeholders face mounting pressure to navigate divergent requirements while maintaining compliance and innovation.

United States Healthcare

HK

Holland & Knight

FDA Turns Up The Heat On GLP 1 Dupes Sold “For Research Use Only,” Finds Intended Use Suggests Otherwise (Podcast)

The FDA has launched a major enforcement initiative against companies marketing unapproved GLP-1 weight loss drug alternatives as "research use only" or "not for human consumption" while simultaneously providing dosing instructions and testimonials. This episode examines how regulators are looking beyond legal disclaimers to focus on actual marketing practices and intended use, signaling heightened scrutiny of the booming market for compounded and unapproved GLP-1 products.

United States Healthcare

KD

Kelley Drye & Warren LLP

DEA Application Portal For Expedited Registration Of Medical Marijuana Dispensaries Is Now Open

As previewed in our recent blog posts (here and here), the DEA application portal for expedited registration of medical marijuana dispensaries is now open and businesses are currently able...

United States Cannabis

FH

Foley Hoag LLP

The Illusion Of PBM Transparency: What Plan Sponsors Must Learn From The OPM OIG Audit Of CVS Caremark

Plan sponsors have been told for years that the answer to rising prescription drug costs is simple. Move to a pass-through PBM arrangement, require transparency, and the incentives will finally align.

United States Finance

BI

Buchanan Ingersoll & Rooney PC

Introducing The Healthcare Class Action Review – 2026: A Deep Dive Into Healthcare Litigation Trends

United States Healthcare

DM

Duane Morris LLP

Capital Snapshot: A Monthly Overview Of The Issues, Events, And Timelines Driving Federal Policy Decisions

Our Legislative & Public Policy team is pleased to provide the April 2026 edition of Capital Snapshot, which includes a monthly summary of the issues, events, and timelines driving federal policy and political decisions.

United States Strategy

AP

Arnold & Porter

Union Accuses Express Scripts Of Illegally Hiding Billions In Drug Company Kickbacks

A Chicago-based union has filed a proposed class action lawsuit against Express Scripts, alleging the pharmacy benefit manager violated RICO by using a Swiss group purchasing organization to hide billions in drug company fees. The lawsuit claims Express Scripts diverted formulary placement fees through Ascent Health Services rather than passing savings to insured parties, breaching its fiduciary duties to help members reduce insurance costs.

United States Employment

HB

Hall Benefits Law

Judge Rotenberg Center Executive Director Glenda Crookes On Federal Policy And Specialized Care (Podcast)

Glenda Crookes, Executive Director of the Judge Rotenberg Center, joins The Lobby Shop to discuss the Massachusetts-based program serving 300 children and adults with autism, developmental disabilities...

United States Healthcare

B

Bracewell

Navigating The New Era Of Healthcare AI: Key Insights From Sheppard’s Inaugural Healthy AI Forum

On April 16, 2026, Sheppard’s Healthy AI team, led by Chicago partner Carolyn Metnick, hosted its inaugural Healthy AI Forum, bringing together healthcare leaders and industry...

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

Class Action Filing Stems From Huntington Ingalls Tobacco Surcharge Compliance

United States Employment

HB

Hall Benefits Law

U.S. Government Puts Fraud And Abuse Focus On Hospice Care In California

United States Healthcare

DM

Duane Morris LLP

AI In Healthcare Translation And Interpretive Services: What Covered Entities Need To Know

United States Technology

SM

Sheppard, Mullin, Richter & Hampton LLP

The Class Action Weekly Wire – Episode 146: Class Action Litigation In The Healthcare Industry (Podcast)

United States Litigation

DM

Duane Morris LLP

DOJ’s FCA Enforcement Priorities — Insights From The Deputy Assistant Attorney General

United States Healthcare

AP

Arnold & Porter

Episode 38: Let’s Talk Compliance: Not All WRVU’s Are Created Equal (Part 1) (Podcast)

United States Healthcare

FL

Foley & Lardner

Amneal Agrees To Acquire Kashiv BioSciences For Total Payment Up To $1.1 Billion

United States Healthcare

GP

Goodwin Procter LLP

Healthcare Emerges At The Center Of Trump 2.0 Antitrust Enforcement

United States Anti-trust

WR

Wiley Rein

IAB Health Privacy Insights

United States Privacy

KD

Kelley Drye & Warren LLP

The Healthcare Class Action Review – 2026: A Deep Dive Into Healthcare Litigation Trends

United States Healthcare

DM

Duane Morris LLP

US Department Of Justice Announces New Initiative For Data Miners Filing False Claims Act Lawsuits

United States Criminal

KG

K&L Gates LLP

Medicare Payment Suspensions Emerge As A Key Tool In Federal Anti-Fraud Efforts — Focus On California Hospices

United States Healthcare

FL

Foley & Lardner

The Healthcare Class Action Review – 2026: A Deep Dive Into Healthcare Litigation Trends

United States Healthcare

DM

Duane Morris LLP

DOJ Fraud Section Launches West Coast Strike Force To Target Health Care Fraud In Arizona, California, Nevada, And Other Western States

United States Criminal

FL

Foley & Lardner

Maine Health Care Transactions: New State Approvals Involving Some Private Equity, Hedge Funds, And MSOs

United States Healthcare

FL

Foley & Lardner

See more

Highlighted Content

Health Care Mediation Strategies: How To Resolve Complex Provider, Reimbursement, And Compliance Disputes (Podcast)

United States Litigation

J

JAMS

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

Taking The Temperature Of Health Care Disputes: The Latest Trends And The Effect Of Business Interruption

United States Litigation

J

JAMS

The Silent Treatment: The EPO's Approach To Non-therapeutic Methods Encompassing Therapeutic Effects

United States Healthcare

D

Dehns

How Best To Resolve Conflicts In The Health Care Setting

United States Litigation

J

JAMS

ADR And Diversity In The Life Sciences Sector

United States Commercial

J

JAMS

[PODCAST] The Pandemic And Beyond: Navigating Disputes Within Health Care Systems

United States Healthcare

J

JAMS

How Alternative Dispute Resolution Can Help Hospital Administrators Handle Conflicts

United States Litigation

J

JAMS

Latest Videos

See more

PBM Reform 2026: What Recent Legislation Means For The Industry (Video)

M

Mintz

A Flurry Of Changes For Plan Sponsors, Prescription Drug Plans And Health Plan Vendors (Video)

RB

Reinhart Boerner Van Deuren s.c.

Leaders In Law: Life Sciences And Technology Transactions With Jekkie Kim (Podcast)

W

WilmerHale

Digging Into New York's New Price-Gouging Rules (Video)

BS

Bond, Schoeneck & King PLLC

Scaling Virtual Care: Dr. Pribitkin's Framework For The Future (Video)

AM

Alvarez & Marsal

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More